News & Media

Press Release

AmacaThera CEO Mike Cooke accepted to adMare BioInnovations 2021-22 Executive Institute

adMare BioInnovations is pleased to announce the nine women and nine men from diverse backgrounds and representing a wide range of life science businesses across the country, selected to join this year’s adMare Academy Executive Institute.Read more

Top20 Amaca Thera FB
Press Release

AmacaThera named CIX Top 20 Early company

Amacathera Inc. has been named a Canadian Innovation Exchange (CIX)’s Top 20 Early company for 2021.Read more

Media Coverage

CBC's Quirks & Quarks features AmacaThera Co-Founder Dr. Molly Shoichet

ICYMI: Thanks to CBC's Quirks and Quarks for re-running this November 2020 interview with our co-founder, Dr. Molly Shoichet.Read more

Press Release

AmacaThera Announces Close of Oversubscribed Series A Financing

Clinical trials set to begin on their proprietary drug delivery platform addresses key problem in sustained therapeutic delivery and is applicable to numerous disease indications and therapeutic modalities​.Read more

SCIENCE hydrogels ROBERTA BAKER molly schoichet web
Media Coverage

Professor Molly Shoichet awarded the Gerzhard Herzberg Canada Gold Medal

Biomedical engineer’s novel hydrogel designs useful for regenerative medicine.Read more

Press Release

AmacaThera Secures Funding to Initiate Phase I Trial of Non-Opioid Pain Control Therapeutic

AmacaThera, a Toronto-based company commercializing hydrogel-based drug delivery platforms, has already raised $3.25 million (CAD) in seed financing from Sprout BioVentures, Viva Biotech, and Grey Sky Venture Partners.Read more

Press Release

Ontario Names Molly Shoichet the Province's First Chief Scientist

Shoichet Will Help Accelerate Scientific Innovation and Advance Science in Government Decision-Making.Read more